openPR Logo
Press release

Imatinib Drug Market Top Companies Analysis To Grow Your Business by 2027, Prominent Players: Novartis, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories

04-01-2020 11:19 AM CET | Health & Medicine

Press release from: Allied Market Research

Imatinib Drug Market

Imatinib Drug Market

Imatinib Drug Market 2020-2027: According to a new report published by Allied Market Research, titled, "Imatinib Drug Market by Application (Aggressive Systemic Mastocytosis (ASM), Chronic Eosinophilic Leukemia (CEL), Dermatofibrosarcoma Protuberans (DFSP), Gastrointestinal Stromal Tumors (GIST), Hyper-eosinophilic Syndrome (HES), Myelodysplastic Syndrome (MDS), Myeloproliferative Diseases (MPD), Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL), and Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML)) and Drug Formulation (Tablets and Capsules) - Global Opportunity Analysis and Industry Forecast, 2020-2027"

Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.

Download Report Sample (320 Pages PDF with Insights) https://www.alliedmarketresearch.com/request-sample/2648

The global market size of Imatinib Drug is $XX million in 2019 with XX CAGR, and it is expected to reach $XX million by the end of 2027 with a CAGR of XX% from 2020 to 2027.

The Major Key Players Are:

o Novartis
o Glenmark Pharmaceuticals Ltd.
o Sun Pharmaceuticals
o Actavis Generics
o Dr. Reddy's Laboratories
o Teva Pharmaceutical Industries Ltd.
o Sanofi S.A.
o Cipla Inc.
o Apotex Inc.
o Mylan Pharms Inc.

Inquire More About This Report Before Making Decision To Purchase: https://www.alliedmarketresearch.com/purchase-enquiry/2648

Key Benefits:

o The study provides an in-depth analysis of the global imatinib drug market, with current trends and future estimations to elucidate the investment pockets.
o Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
o The report presents a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
o Extensive analysis of different segments facilitates to understand various products of the market.
o Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.

Imatinib Drug Market Key Segments:

By Application

o Aggressive Systemic Mastocytosis (ASM)
o Chronic Eosinophilic Leukemia (CEL)
o Dermatofibrosarcoma Protuberans (DFSP)
o Gastrointestinal Stromal Tumors (GIST)
o Hyper-eosinophilic Syndrome (HES)
o Myelodysplastic Syndrome (MDS)
o Myeloproliferative Diseases (MPD)
o Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
o Philadelphia Chromosome-positive Chronic Myeloid Leukemia (Ph+ CML)

By Drug Formulation

o Tablets
o Capsules

By Region

o North America
o Europe
o Asia-Pacific
o LAMEA

Access Full Report @ https://www.alliedmarketresearch.com/imatinib-drug-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Imatinib Drug Market Top Companies Analysis To Grow Your Business by 2027, Prominent Players: Novartis, Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics, Dr. Reddy's Laboratories here

News-ID: 1994325 • Views: 329

More Releases from Allied Market Research

Drug Screening Laboratory Services Market Share Size, Statistics, Demand, Revenu …
Drug Screening Laboratory Services Market by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil & Gas, Transportation, Staffing, Government, Other Workplace, Hospital Laboratories, Clinical Laboratories, and Other Laboratories): Global Opportunity Analysis and Industry Forecast, 2020-2027 by Service type, (Workplace Drug Testing and Clinical Toxicology Testing), Sample Type (Urine, Oral Fluid, Hair and Others), End User (Retail, Oil
Orthopedic Devices Market Global Growth, Current Scenario Technology Trends, Com …
Rise in geriatric population and increase in chronic diseases related to orthopedics such as osteoarthritis, traumatic fractures, osteopenia, and others are play a major role in the growth of the orthopedic device market. In addition, various growth opportunities such as surge in healthcare infrastructure, increase in affordability, and rise in awareness related to orthopedic conditions in emerging economies are expected to boost the market growth in the coming years. Download Free
Neurosurgery Devices Market: Global Trends, Segmentation and Opportunities Forec …
Neurosurgery devicesare devices that help in prevention, treatment, and diagnosis of conditions and disorders associated with nervous system mainly the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system. The neurological conditions include dementia, headache disorders, neuro-infections, and multiple sclerosis, traumatic brain injuries, pain associated with neurological disorders, neurological disorders associated with malnutrition, stroke, epilepsy and Parkinson’s disease.These disorders are fatal and cannot be cured by therapeutics. Some of the
COVID-19 Impact on Nerve Repair and Regeneration Market Global Industry Size, Sh …
Global Nerve Repair and Regeneration Market are expected to reach $13,938 million by 2023, growing at a CAGR of 13.0 % during the forecast period, 2019-2023. The factors propelling the nerve repair and regeneration market are rise in geriatric population, growing prevalence of neurological and epidemic disorders, and introduction of novel and innovative products for nerve repair and regeneration. However, stringent regulatory requirements for product approvals, lack of skilled professionals, and

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning